Dana M Sepe

Summary

Affiliation: The Children's Hospital of Philadelphia
Country: USA

Publications

  1. ncbi Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database
    Dana M Walker
    Division of Oncology, The Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Pediatr Blood Cancer 60:616-20. 2013
  2. ncbi Germline genetic variation and treatment response on CCG-1891
    Dana M Sepe
    The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 4318, USA
    Pediatr Blood Cancer 58:695-700. 2012
  3. ncbi Dexrazoxane as a cardioprotectant in children receiving anthracyclines
    Dana M Sepe
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Oncologist 15:1220-6. 2010

Collaborators

Detail Information

Publications3

  1. ncbi Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database
    Dana M Walker
    Division of Oncology, The Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Pediatr Blood Cancer 60:616-20. 2013
    ....
  2. ncbi Germline genetic variation and treatment response on CCG-1891
    Dana M Sepe
    The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 4318, USA
    Pediatr Blood Cancer 58:695-700. 2012
    ..We sought to extend current knowledge by using standard and novel statistical methodology to examine polymorphic variants of genes and relapse risk, toxicity, and drug dose delivery in standard risk ALL...
  3. ncbi Dexrazoxane as a cardioprotectant in children receiving anthracyclines
    Dana M Sepe
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Oncologist 15:1220-6. 2010
    ..Continued follow-up from previous trials is needed to determine the long-term effect of dexrazoxane on cardiac outcomes and quality of life...